163 related articles for article (PubMed ID: 35428456)
21. Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.
Pearson AD; DuBois SG; Buenger V; Kieran M; Stegmaier K; Bandopadhayay P; Bennett K; Bourdeaut F; Brown PA; Chesler L; Clymer J; Fox E; French CA; Germovsek E; Giles FJ; Bender JG; Hattersley MM; Ludwinski D; Luptakova K; Maris J; McDonough J; Nikolova Z; Smith M; Tsiatis AC; Vibhakar R; Weiner S; Yi JS; Zheng F; Vassal G
Eur J Cancer; 2021 Mar; 146():115-124. PubMed ID: 33601323
[TBL] [Abstract][Full Text] [Related]
22. Challenges and Opportunities in NUT Carcinoma Research.
Hakun MC; Gu B
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562801
[TBL] [Abstract][Full Text] [Related]
23. HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report.
Esteves G; Ferreira J; Afonso R; Martins C; Zagalo C; Félix A
Head Neck Pathol; 2020 Dec; 14(4):1117-1122. PubMed ID: 31989434
[TBL] [Abstract][Full Text] [Related]
24. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
[TBL] [Abstract][Full Text] [Related]
25. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
[TBL] [Abstract][Full Text] [Related]
26. Report of the First International Symposium on NUT Carcinoma.
French CA; Cheng ML; Hanna GJ; DuBois SG; Chau NG; Hann CL; Storck S; Salgia R; Trucco M; Tseng J; Stathis A; Piekarz R; Lauer UM; Massard C; Bennett K; Coker S; Tontsch-Grunt U; Sos ML; Liao S; Wu CJ; Polyak K; Piha-Paul SA; Shapiro GI
Clin Cancer Res; 2022 Jun; 28(12):2493-2505. PubMed ID: 35417004
[TBL] [Abstract][Full Text] [Related]
27. Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment.
Shiota H; Alekseyenko AA; Wang ZA; Filic I; Knox TM; Luong NM; Huang Y; Scott DA; Jones KL; Gokhale PC; Lemieux ME; Cole PA; Kuroda MI; French CA
Mol Cancer Res; 2021 Nov; 19(11):1818-1830. PubMed ID: 34285087
[TBL] [Abstract][Full Text] [Related]
28. NUT midline carcinoma of the head and neck: current perspectives.
Napolitano M; Venturelli M; Molinaro E; Toss A
Onco Targets Ther; 2019; 12():3235-3244. PubMed ID: 31118674
[No Abstract] [Full Text] [Related]
29. Primary Thyroid NUT Carcinoma With High PD-L1 Expression and Novel Massive
Zhou J; Duan M; Jiao Q; Chen C; Xing A; Su P; Tang J; Zhang H; Liu Z
Front Oncol; 2021; 11():778296. PubMed ID: 35127482
[TBL] [Abstract][Full Text] [Related]
30. NUT Midline Carcinoma: A Rare Solid Tumour Characterized by Chromosome Rearrangement.
Zhang H; Kong W; Liang W
Evid Based Complement Alternat Med; 2022; 2022():3369895. PubMed ID: 35832518
[TBL] [Abstract][Full Text] [Related]
31. NUT midline carcinoma of the larynx: an international series and review of the literature.
Hellquist H; French CA; Bishop JA; Coca-Pelaz A; Propst EJ; Paiva Correia A; Ngan BY; Grant R; Cipriani NA; Vokes D; Henrique R; Pardal F; Vizcaino JR; Rinaldo A; Ferlito A
Histopathology; 2017 May; 70(6):861-868. PubMed ID: 27926786
[TBL] [Abstract][Full Text] [Related]
32. Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature.
Wang H; Weiss VL; Hoffman RD; Abel T; Ho RH; Borinstein SC; Mannion K; Bridge JA; Black J; Liang J
Head Neck Pathol; 2021 Mar; 15(1):236-243. PubMed ID: 32077054
[TBL] [Abstract][Full Text] [Related]
33. Primary renal NUT carcinoma identified by next-generation sequencing: a case report and literature review.
Yang F; Shen D; Shi J
Int J Clin Exp Pathol; 2021; 14(5):662-669. PubMed ID: 34093952
[TBL] [Abstract][Full Text] [Related]
34. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.
Stelow EB; Bellizzi AM; Taneja K; Mills SE; Legallo RD; Kutok JL; Aster JC; French CA
Am J Surg Pathol; 2008 Jun; 32(6):828-34. PubMed ID: 18391746
[TBL] [Abstract][Full Text] [Related]
35. Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment.
Kaplan HG; Subramaniam S; Vallières E; Barnett T
Oncologist; 2023 Sep; 28(9):765-770. PubMed ID: 37311046
[TBL] [Abstract][Full Text] [Related]
36. "Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.
Shiota H; Elya JE; Alekseyenko AA; Chou PM; Gorman SA; Barbash O; Becht K; Danga K; Kuroda MI; Nardi V; French CA
Mol Cancer Res; 2018 Dec; 16(12):1826-1833. PubMed ID: 30139738
[TBL] [Abstract][Full Text] [Related]
37. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
[TBL] [Abstract][Full Text] [Related]
38. Incidence of NUT carcinoma in Western Australia from 1989 to 2014: a review of pediatric and adolescent cases from Perth Children's Hospital.
Carter T; Crook M; Murch A; Beesley AH; de Klerk N; Charles A; Kees UR
BMC Cancer; 2021 Jun; 21(1):740. PubMed ID: 34176480
[TBL] [Abstract][Full Text] [Related]
39. CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.
Schaefer IM; Dal Cin P; Landry LM; Fletcher CDM; Hanna GJ; French CA
Genes Chromosomes Cancer; 2018 Sep; 57(9):446-451. PubMed ID: 29700887
[TBL] [Abstract][Full Text] [Related]
40. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
